PRTN3 and rheumatoid arthritis: To envisage how ACPAs modulate pathways in RA pathogenesis, it could be instrumental to analyze and better understand the impact of clonal variability, as different types of ACPA effects can be expected in patients carrying different ACPA repertoires.